key: cord-0015442-4p6xjpaa
authors: Liu, Min; Li, Weixin; Song, Fuxing; Zhang, Ling; Sun, Xianjun
title: Silencing of lncRNA MIAT alleviates LPS-induced pneumonia via regulating miR-147a/NKAP/NF-κB axis
date: 2020-12-09
journal: Aging (Albany NY)
DOI: 10.18632/aging.202284
sha: e0f0feab50597251ca931246bdca2a6bc346d611
doc_id: 15442
cord_uid: 4p6xjpaa

Purpose: Pneumonia is a respiratory disease with an increasing incidence in recent years. More and more studies have revealed that lncRNAs can regulate the transcriptional expression of target genes at different stage. Herein, we aimed to explore the effect of lncRNA MIAT in LPS-induced pneumonia, and further illuminate the possible underlying mechanisms. Method and results: Mice were intraperitoneally injected with LPS, and the lung inflammation was evaluated. Microarray showed lncRNA MIAT was up-regulated in LPS-induced pulmonary inflammation. And qRT-PCR and FISH assay indicated that MIAT was increased in mice with LPS injection. Functional analysis showed sh-MIAT inhibited LPS-induced inflammation response, inhibited apoptosis level and protected lung function. As well, si-MIAT removed the injury of LPS on mouse lung epithelial TC-1 cells, and inhibited the activation of NF-κB signaling. Furthermore, MIAT acted as a sponge of miR-147a, and miR-147a directly targeted NKAP. Functionally, AMO-147a or NKAP remitted the beneficial effects of si-MIAT on LPS-induced inflammation response of TC-1 cells. Conclusion: Deletion of MIAT protected against LPS-induced lung inflammation via regulating miR-147a/NKAP, which might provide new insight for pneumonia treatment.

Pneumonia is a respiratory disease with an increasing incidence in recent years [1] . In particular, children are extremely prone to pneumonia, with an incidence of up to 30% in the peak season [2] . When the pathogenic microorganism invades the host, it can stimulate the immune system to produce inflammatory factors, which accumulate locally [3] . On the other hand, the descending infection department caused respiratory tract infection, and the clinical manifestations were not bronchitis, pneumonia and so on. In severe cases, it can accumulate in the brain, heart, liver and kidney, followed by encephalitis, myocarditis and hepatitis and other complications [4] . However, at present, the pathogenesis of childhood pneumonia is still controversial and there are still difficulties in clinical treatment, so it is of great significance to explore the pathogenesis of childhood pneumonia at the molecular level.

More than 80% of the genes in the human genome are transcribed, yet less than 2% of the genes encode proteins [5] . In addition to tRNA and rRNA, these non-coding transcriptional sequences have a variety of regulatory RNA [6] . In the past 10 years, AGING researchers have focused on the study of non-coding RNA. With the development of gene chip, highthroughput sequencing, RNA pull-down and other technologies, lncRNA has gradually entered people's attention and become a research hotspot at home and abroad [7] . At first, people thought that lncRNA is the "noise" of genome transcription [8] . However, recent studies have found that lncRNA is involved in transcriptional regulation, post-transcriptional regulation, genomic imprinting, epigenetics and so on [9] . LncRNA can also be used as a "bait" to combine with miRNA to play the "sponge" role of miRNA, thus regulating a series of pathophysiological processes [10] . It has been found that lncRNA and miRNA play an important role in the occurrence, development, treatment and prognosis of respiratory diseases [11] .

Pneumonia is often accompanied by lung injury [12, 13] , which turns into pulmonary edema and neutrophil accumulation [14, 15] . Zhang et al. [16] found that lncRNA FOXD3-AS1 was the most significantly upregulated lncRNAs in hyperoxia-induced acute lung injury model. The team determined the luciferase activity of FOXD3-AS1 and miR-150 and found that FOXD3-AS1 could be used as a sponge for miR-150. In the model of lung injury, miR-150 has a cytoprotective effect, while FOXD3-AS1 can promote cell death, which may be that FOXD3-AS1, as the "sponge" of miR-150, limits the cytoprotective effect of miR-150, thus exaggerating the cell death induced by hyperoxia. In addition, Wu et al. [17] found that lncRNA H19 inhibits lipopolysaccharide-induced injury by inhibiting the expression of miR-181a and indirectly increasing the expression of Runx2, the downstream target of miR-181a. At the same time, the overexpression of Runx2 is related to the activation of JNK and Notch signal pathways. This study suggests that H 19 may be involved in acute lung injury by regulating JNK and Notch signal pathways through its sponge effect.

LncRNA MIAT (myocardial infarction associated transcript) is a kind of lncRNA which is mainly expressed in cardiomyocytes and kidney cells, and has the function of regulating protein synthesis [18, 19] . Linn Fagerberg et al. used microarray technology to analyze the transcriptome of human tissues and organs, and found that MIAT was highly expressed in bone marrow, indicating that bone marrow is one of the main sites of MIAT [20] . In addition, MIAT has been found to play an important role in the occurrence of many diseases, mainly related to the activation of inflammatory response [21, 22] . Therefore, we speculate that lncRNA MIAT may participate in the progression of pneumonia by regulating inflammatory response. Herein, we explored the effect of lncRNA MIAT in pneumonia, and further illuminate the possible underlying mechanisms.

We first established mouse model of pneumonia by intraperitoneally injecting LPS, and the inflammation of lungs was evaluated. LPS treatment significantly increased the infiltration of inflammatory cell and induced the pulmonary edema ( Figure 1A ). LPS injection increased wet dry mass ratio (W/D) of isolated lungs, indicating that LPS treatment induced pulmonary edema ( Figure 1B ). Then qRT-PCR also indicated that the expression of inflammatory factors IL 1β, IL 6 and TNFα was upregulated upon LPS stimulation ( Figure  1C ). Alveolar epithelial cells are involved in maintaining normal lung function, so we estimated alveolar epithelial cells function by examining epithelial markers expression. LPS administration reduced the mRNA expressions of E-cadherin and Sftpc ( Figure  1D ). Above data proved that the mouse pneumonia model was established successfully. Then, we performed Microarray analysis, and the data showed the differentially expressed lncRNAs in saline and LPS treatment of lung tissues, which showed an increase of MIAT in LPS-treated lung tissues ( Figure 1E ). Then qRT-PCR also indicated that MIAT was upregulated in LPS-treated lung tissues comparing with saline-treated lung tissues ( Figure 1F ). Then, FISH assay showed that MIAT expression, predominantly located in the cytoplasm, was dramatically raised in lung tissue of LPS stimulation ( Figure 1G ).

For further research, we constructed lentiviral plasmid for knockdown the expression of MIAT (LV-sh-MIAT, LV-sh-NC was indicated as a control group), and intratracheally injected into mice (Figure 2A ). The survival curve showed that LPS significantly inhibited the survival rate of mice, while deletion of MIAT decreased the mice mortality compared with LPS group ( Figure 2B ). Histological examination showed that LPS caused structural damage of lung tissue in mice, accompanied by apparent inflammatory cell infiltration and alveolar hemorrhage. LV-sh-MIAT could significantly alleviate the above pathological changes induced by LPS ( Figure 2C ). LPS stimulation increased wet dry mass ratio (W/D) of isolated lungs, while LVsh-MIAT injection decreased W/D, indicating that sh-MIAT inhibited pulmonary edema ( Figure 2D ). Then, AGING we collected and calculated macrophages and neutrophils in alveolar lavage fluid LPS injection promoted the numbers of macrophages and neutrophils, while sh-MIAT inhibited the aggregation of macrophages and neutrophils ( Figure 2E , 2F). As well, sh-MIAT inhibited the increase of myeloperoxidase (MPO) in LPS-treated lungs ( Figure 2G ). In addition, silencing of MIAT inhibited inflammatory factors expression ( Figure 2H) , and restored the level of Ecadherin and Sftpc comparing with LPS treatment group ( Figure 2I ).

In vitro, we cultured TC-1 cells treated with LPS (100 ng/mL) to mimic in vivo LPS-induced pneumonia. And siRNA of MIAT was transfected into cells with LPS treatment ( Figure 3A ). MTT results showed that LPS treatment decreased cell viability, while si-MIAT recover cell viability and remitted the injury effects of LPS ( Figure 3B ). In addition, TUNEL analysis exhibited an increase of apoptotic cell numbers in LPS treated TC-1 cells, while si-MIAT decreased apoptotic cell numbers ( Figure 3C ). As well, LPS promoted the expression of cleaved-caspase-3 and Bax/Bcl2, which was reversed by si-MIAT transfection ( Figure 3D ). Flow cytometry assay showed that si-MIAT inhibited both early and late apoptotic cell numbers ( Figure 3E ). Moreover, LPS induced the expression of inflammation factors, while si-MIAT reduced inflammation factors level ( Figure 3F , 3G). NF-κB signaling exerts an essential function in inflammation response. LPS treatment activated NF-κB signaling with increasing expression of p-IκBα and p-p65, but this effect was reversed by si-MIAT transfection ( Figure 3H ).

To explore the molecular mechanism of MIAT in LPSinduced pneumonia, we used miRanda database and found a potential binding between MIAT and miR-147a ( Figure  4A ). Then luciferase assay showed miR-147a inhibited activity of WT MIAT not mut MIAT in HEK293 cells ( Figure 4B ). And overexpression of MIAT inhibited miR-147a level, while silencing of MIAT promoted miR-147a level in TC-1 cells ( Figure 4C ). Further, endogenous MIAT was enriched in biotinylated miR-147a transfected AGING TC-1 cells, which reveals a direct binding of MIAT with miR-147a ( Figure 4D ).

Through Targetscan we found bases pairing of miR-147a and NKAP ( Figure 5A ). Followed luciferase. analysis suggested miR-147a directly inhibited NKAP expression ( Figure 5B ). Furthermore, miR-147a suppressed NKAP mRNA and protein expression, but AMO-147a increased NKAP level in TC-1 cells ( Figure  5C and 5D). RIP assay showed an enrichment of miR-147a in biotinylated NKAP cells.

We then inhibited expression of MIAT with AMO-147a or NKAP in TC1 cells ( Figure 6A ). Knockdown of MIAT inhibited LPS-induced apoptosis, inflammation response and NF-κB signaling AGING activation ( Figure 6B-6G) . However, AMO-147a or NKAP removed the beneficial role of si-MIAT on TC-1 cells ( Figure 6B-6H) . Moreover, LV-sh-MIAT was intratracheally injected into mice with or without AMO-147a, and the expression of MIAT and miR-147a in lung tissues was detected using qRT-PCR ( Figure 7A ). Followed functional experiments showed that AMO-147a reversed the protected effects of sh-MIAT in LPS-treated lungs ( Figure 7B-7F) .

Pneumonia is a common infectious disease in children [23] . The pathogenesis of pneumonia is complicated, which is often accompanied by immune response and inflammation, which will seriously damage the function of lung tissue [24] . LncRNA is one of the most important nucleotides in recent years. More and more studies have revealed that lncRNAs can regulate the transcriptional expression of target genes at different stages, and levels of cell growth [25] . Present study showed a high expression of lncRNA MIAT in LPS-induced inflammation and injury of lung tissues and cells. Silencing of MIAT removed the adverse effects of LPS on lung tissues and cells, and inhibited apoptosis level, accumulation of inflammatory factors and activation of NF-κB signaling. Mechanismly, deletion of MIAT protected against LPS-induced inflammation and injury via miR-147a/NKAP axis.

Lung injury is the most direct consequence of pneumonia, which is characterized by inflammatory damage to the alveolar capillary membrane and the production of inflammatory cytokines [26, 27] . Inflammatory response and inflammatory cytokines play an important role in the pathogenesis of pneumonia [28] . Animal experiments have shown that LPS stimulation can induce acute inflammatory AGING response and lead to early histopathological changes in the lung [29] . Inhibition of LPS-induced inflammation may be an effective method for the treatment of pneumonia [30] . We injected LPS into the abdominal cavity of mice to induce pulmonary inflammation. The expression of lncRNA was analyzed by high-throughput sequencing, and the differentially expressed lncRNA was found. Although the differential expression of these lncRNA is affected by LPS stimulation, whether they can regulate the inflammatory response induced by LPS still needs to be further verified, but this method can help us to find possible target molecules. Our data showed a significant increase of MIAT in mice with LPS injection.

As a non-coding RNA, lncRNA can interact directly with DNA, RNA, proteins and play a variety of regulatory functions [31] . MALAT1, CCL2, MALAT1, and HAGLROS, which regulate inflammatory response through inflammation-related mediators, are all involved in the regulation of inflammatory response in lung injury [32] [33] [34] [35] . LncRNA MIAT is first identified in heart tissues and known as myocardial infarction-associated transcript [36] . Then followed studies show that MIAT is associate with inflammation of different tissues [37, 38] . LncRNA MIAT was increased in diabetic cardiomyopathy. And the high expression of MIAT is closely related to the production proinflammatory IL-17. Further data indicated that MIAT specific suppressed miR-214-3p expression, then removed the inhibitory effect of miR-214-3p on IL-17 expression [21] . Meanwhile, LPS-induced septic cardiomyopathy elevated MIAT expression in heart tissues. Knockdown of MIAT inhibited the inflammatory response and oxidative stress induced by LPS. Further data showed MIAT could activate RAF6/NF-κB signaling and then accelerate inflammation [39] .

In present study, we injected lentiviral plasmid to inhibited MIAT expression in LPS injected mice. Functional data showed that sh-MIAT promoted mouse survival, inhibited LPS-induced inflammation response and protected lung function. Alveolar epithelial cells are important cells in the biological function of lung tissue. And we silenced MIAT expression in mouse lung epithelial cells TC-1. Consistent with in vivo results, si-MIAT removed the injury of LPS on TC-1 cells, and inhibited accumulation of inflammatory factors. The inflammatory pathway mediated by NF-κB, STAT3 and other related transcription factors is the main pathway of macrophage inflammatory response [40] . Phosphorylation of NF-κB and other transcription factors into the nucleus can affect the transcription of inflammatory cytokines IL-1β and TNFα in the nucleus [41] . LncRNAs have been proved to play a regulatory role by affecting transcription factors [42] . Therefore, we speculate that, lncRNA MIAT may inhibit inflammation by affecting transcription factors associated with inflammatory pathways. As well, si-MIAT inhibited the phosphorylation of IκBα and p65, thus inhibited the activation of NF-κB pathway.

Furthermore, we found that MIAT acted as a sponge of miR-147a, and miR-147a directly targeted NKAP. Accumulating evidences have shown that lncRNAs regulate miRNA abundance by binding or chelating miRNA, and play the "sponge" role of lncRNAs, thus regulating a series of pathophysiological processes [43] . miR-147a has been reported to relate to non-small-cell lung cancer [44] . And NKAP is a nuclear protein that activates NF-κB [45] . LPS treatment induced the expression of NKAP in human corneal fibroblasts [46] . And present results showed that AMO-147a or NKAP remitted the beneficial effects of si-MIAT on LPSinduced inflammation response. Together, silencing of MIAT alleviates LPS-induced pulmonary inflammation and injury via regulating miR-147a/NKAP axis.

In summary, our data revealed that knockdown of MIAT protected against LPS-induced pulmonary inflammation and injury, which was mediated by miR-147a/NKAP axis. And this study might provide new understanding for pneumonia mechanism, and be helpful for pneumonia treatment.

After intraperitoneal injection of 22 mg/mL pentobarbital sodium (diluted with normal saline), the caudal root, hindlimb, and eyelash reflexes disappeared after 10 min, and slow breathing was considered as deep anesthesia. Nasopharyngeal drip: LPS saline solution was prepared according to 167um g/mL. After anesthesia, the mouse head was tilted downward, and the tongue was pulled out with tweezers. The 60 μL LPS saline solution (about 10 μg LPS) was absorbed by a fluid transfer gun and dropped into the oral cavity through the posterior wall of the pharynx. The nostril was quickly pinched and maintained for 30 seconds, and the model was successful when all the liquid was absorbed into the nasal cavity, and slight tracheal rales appeared. 150 μL lentivirus containing MIAT-shRNA/NC-shRNA or AMO-147a was intratracheally injected into mice. 21 days after the establishment of the model, mice were intraperitoneally injected with 3% pentobarbital sodium and were euthanatized by excessive anesthesia with a dose of 90 mL/kg, and the organs and tissues were removed for follow-up study. Moreover, macrophages and neutrophil in alveolar lavage fluid were collected as previous described [47] . The research protocol of this study was approved by the Animal Care and Use Committee of the AGING Jinan People's Hospital Affiliated to Shandong First Medical University.

The TC-1 cell lines (Mouse alveolar epithelial cells) were purchased from the Science Cell Laboratory. Cell lines were cultured in DMEM (Thermo-life, United States) with 10 % FBS (Thermo Fisher, USA) and 100 μL/mL penicillin and streptomycin (Beyotime, China) and placed at 37° C with 5% CO2. The TC-1 cells were plated until the cell density reached 80% confluency of dishes to transfect. Anti-miRNA oligonucleotide of miR-147a (AMO-147a) or small interfering RNA (si-RNA) of MIAT or NKAP and were constructed by Genechem (Shanghai, China). The plasmids transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA). LPS was added into cells at a concentration of 100 ng/mL for 6 h.

TC-1 cells were plated in 96-well plates and we used MTT assay to detect the cell viability. MTT (0.5 mg/mL; Beyotime Biotechnology, China) was added to every well after treatment and incubated for 3 h at 37° C. And 150 μL DMSO was added and incubated for 15 min. We measured the absorbance by Spectrophotometer (Tecan, Austria) at 493 nm.

RNA extraction was performed using trizol reagent. NanoDrop 8000 (Thermo Scientific, Waltham, MA, USA) was used to detect the concentration and purity of RNA. The single-stranded cDNAs were synthesized from 1 μg of RNA. The expression of mRNAs and miRNAs were quantified by RT-PCR with SYBR Green I (Thermo Fisher Scientific, Inc).

After RIPA cleavage, we extracted total protein and measured with BCA method. After quantitative denaturation, protein electrophoresis membrane transfer and blocked. The first incubation and second incubation were carried out according to the operation steps. The expression of the protein was expressed by the gray value. Primary antibodies list: GADPH (ab181602, Abcam), cleaved-caspase3 (ab2302, Abcam), bax (ab32503, Abcam), bcl2 (12789-1-AP, Proteintech), TNFα (17590-1-AP, Proteintech), IL 6 (66146-1-Ig, Proteintech), p-IκBα ((ab92700, Abcam), IκBα (10268-1-AP, Proteintech), p65 (66535-1-Ig, Proteintech) and p-p65 (ab183559, Abcam). The secondary antibodies IRDye700/800 Mouse or Rabbit were produced by LICOR (Lincoln, Nebraska, USA).

HEK293 cells were co-transfected with 20 mmol/L miR-147a mimic or miR-NC together with WT-MIAT/Mut-MIAT or WT-NKAP/Mut-NKAP. Luciferase activity was measured with Dual Luciferase Reporter Assay Kit (Transgene, China) on GloMax20/20 at 48 h after the transfection.

We used RIP assay to determine the binding between MIAT/NKAP and miR-147a using Magna RIP™ RNA-Binding Protein Immunoprecipitation Kit (Millipore) as previous study [48] . Briefly, TC-1 cells were transfected with biotinylated miR-147a/miR-NC or NKAP/NC, and the mRNA level of MIAT or miR-147a was detected using qRT-PCR.

The lung tissues were gathered and fixed in 4% paraformaldehyde for 24 hrs. Then the fixed tissues were embedded in paraffin. Next, Paraffin slicer machine was used to cut slices (5-mm cross-sectional). H&E staining was used to evaluate pulmonary morphology. Lung sections were dewaxed with xylene and treated with ethanol at different concentrations for 5 minutes. Hematoxylin staining for 5 minutes, 5% acetic acid treatment for 1 minute, water rinse. Dye with eosin for 1 minute, rinse with running water. Dehydrate in 70%, 80%, 90%, 100% ethanol for 10 seconds, xylene for 1 minute. Drizzle with neutral gum and seal.

We used the in situ Cell Death Detection Kit (TUNEL fluorescence FITC kit, Roche, Germany) detect apoptotic. We used DAPI to stain nuclei. We used IX73 fluorescence microscope (Olympus, Valley, PA) to analyze fluorescence staining. We used Image-J to count the Total cells and TUNEL positive cells numbers.

Cell apoptosis was calculated by Annexin V apoptosis kit (Beyotime, China), and the operating procedure was according to the kit instructions. Briefly, 5×10 5 cells/mL were centrifuged and resuspended in with Annexin V-FITC and PI solution in darkness for 15 min. Then, Binding Buffer was mixed into the resuspension and detected with instrument. Cell apoptosis level was detected within 1 h.

The sample was grown or adhered to or sliced on the cover slide and permeated with 70% ethanol. Hybridization can be done in a traditional laboratory incubator at 37° C within 4 hours. After hybridization, the washing buffer was incubated briefly to remove the excess probe. The total time is 1-1.5 hours. The sample can be imaged using a standard fluorescence microscope.

Data were shown as mean±SD. Student's t-test or oneway ANOVA was used to compare the groups. P<0.05 was considered significance.

ML and WXL performed the experiments and collected data. FXS and LZ conceived experiments and analyzed data. XJS wrote this manuscript. All the authors were involved in editing the paper and had final approval of the revised versions.

The author reports no conflicts of interest in this work.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-forprofit sectors.

Enhanced surveillance for severe pneumonia

Parainfluenza virus types 1-3 infections among children and adults hospitalized with community-acquired pneumonia

The lncRNA Neat1 promotes activation of inflammasomes in macrophages

Influenza virus-related critical illness: pathophysiology and epidemiology

Circulating MicroRNA and long noncoding RNA as biomarkers of cardiovascular diseases

Non-coding Transcripts from Enhancers: New Insights into Enhancer Activity and Gene Expression Regulation

Basic biology and therapeutic implications of lncRNA

Long noncoding RNAs: functional surprises from the RNA world

RNA in unexpected places: long noncoding RNA functions in diverse cellular contexts

An ultraconserved lnc to miRNA processing

Long noncoding transcriptome in chronic obstructive pulmonary disease

Chronic alcohol ingestion worsens survival and alters gut epithelial apoptosis and CD8+ T cell function after pseudomonas aeruginosa pneumonia-induced sepsis

Houttuynia cordata polysaccharides ameliorate pneumonia severity and intestinal injury in mice with influenza virus infection

Myeloid but not epithelial tissue factor exerts protective anti-inflammatory effects in acid aspirationinduced acute lung injury

G-CSF maintains controlled neutrophil mobilization during acute inflammation by negatively regulating CXCR2 signaling

Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis via sponging microRNA-150

Overexpression of long non-coding RNA H19 protects lung fibroblasts from LPS-induced injury by targeting miR-181a and Runx2 via activation of notch and JNK pathways

Long Non-Coding RNAs in Cardiac Remodeling

Long noncoding MIAT mediates high glucose-induced renal tubular epithelial injury

The human testisspecific proteome defined by transcriptomics and antibody-based profiling

LncRNA-MIAT-mediated miR-214-3p silencing is responsible for IL-17 production and cardiac fibrosis in diabetic cardiomyopathy

LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation

Prevalence of immunodeficiency in children with invasive pneumococcal disease in the pneumococcal vaccine era: a systematic review

Microinvasion by streptococcus pneumoniae induces epithelial innate immunity during colonisation at the human mucosal surface

Long noncoding RNAs in development and disease of the central nervous system

Recent insights into pulmonary repair following virus-induced inflammation of the respiratory tract

Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factorbeta, during the course of experimental pulmonary tuberculosis

Immune response, inflammation, and the clinical spectrum of COVID-19

Knockdown of versican V1 induces a severe inflammatory response in LPSinduced acute lung injury via the TLR2-NF-κB signaling pathway in C57BL/6J mice

Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis

Immunobiology of long noncoding RNAs

Long non-coding RNAs (lncRNAs) and their transcriptional control of inflammatory responses

SIRT1 regulates inflammation response of macrophages in sepsis mediated by long noncoding RNA

Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury

Long noncoding RNA HAGLROS regulates cell apoptosis and autophagy in lipopolysaccharides-induced WI-38 cells via modulating miR-100/NF-κB axis

Myocardial infarction-associated transcript, a long noncoding RNA, is overexpressed during dilated cardiomyopathy due to chronic chagas disease

Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes

Molecular regulatory pathways link sepsis with metabolic syndrome: non-coding RNA elements underlying the sepsis/metabolic cross-talk

LncRNA MIAT promotes inflammation and oxidative stress in sepsis-induced cardiac injury by targeting miR-330-5p/TRAF6/NF-κB axis

Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression

LRP1 knockdown aggravates Aβ1-42-stimulated microglial and astrocytic neuroinflammatory responses by modulating TLR4/NF-κB/MAPKs signaling pathways

LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β

Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH

Sodium new houttuyfonate suppresses metastasis in NSCLC cells through the Linc00668/miR-147a/slug axis

Identification of a nuclear protein that promotes NF-kappaB activation

LncRNA NEAT1 promotes inflammatory response and induces corneal neovascularization

Distinct expression of coinhibitory molecules on alveolar T cells in patients with rheumatoid arthritis-and idiopathic inflammatory myopathies-associated interstitial lung disease. Arthritis Rheumatol

Long noncoding RNA LCAT1 functions as a ceRNA to regulate RAC1 function by sponging miR-4715-5p in lung cancer